By Britain Eakin ยท February 19, 2021, 5:36 PM EST
Evolus and Allergan announced a deal Friday that resolves trade secret theft allegations against Evolus, allowing Evolus’ low-cost version of Allergan’s Botox to stay on the market in the U.S. in…
To view the full article, register now.
